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One of the most striking epigenetic alterations that occurs at the level of the nucleosome is the complete exchange of the canoni-
cal H2A histones for the macroH2A variant. Here, we provide insight into the poorly recognized function of macroH2A in tran-
scriptional activation and demonstrate its relevance in embryonic and adult stem cells. Knockdown of macroH2A1 in mouse
embryonic stem (mES) cells limited their capacity to differentiate but not their self-renewal. The loss of macroH2A1 interfered
with the proper activation of differentiation genes, most of which are direct target genes of macroH2A. Additionally,
macroH2A1-deficient mES cells displayed incomplete inactivation of pluripotency genes and formed defective embryoid bodies.
In vivo, macroH2A1-deficient teratomas contained a massive expansion of malignant, undifferentiated carcinoma tissue. In the
heterogeneous culture of primary human keratinocytes, macroH2A1 levels negatively correlated with the self-renewal capacity
of the pluripotent compartment. Together these results establish macroH2A1 as a critical chromatin component that regulates
the delicate balance between self-renewal and differentiation of embryonic and adult stem cells.
Chromatin and its alterations provide the molecular basis forthe epigenetic memory of a cell. During cell fate transitions,
such as differentiation and development, chromatin modifica-
tions need to be removed and new ones set in a highly concerted
manner (22). During the past years, we have begun to understand
how this is achieved for many of the posttranslational modifica-
tions of the histone tails and the DNA itself. However, remarkably
little is known about the role and regulation of a much more
extensive chromatin alteration, namely, that of exchanging a ca-
nonical histone for a variant protein. Numerous histone variants
exist for the histones H3 and H2A (39). Among these, macroH2A
stands out because of its unique size and domain structure. A
C-terminal linker connects the histone fold domain ofmacroH2A
to a macro domain. This domain protrudes from the compact
structure of the nucleosome and is likely to affect the function and
organization of the surrounding chromatin (11). Three different
proteins, termed macroH2A1.1, macroH2A1.2, and macroH2A2,
are generated from two genes and alternative splicing of the pri-
mary macroH2A1 mRNA (reviewed in reference 7). Unless spec-
ified, we will refer to these as macroH2A (for all three forms) or
macroH2A1 (for macroH2A1.1 and macroH2A1.2).
Inembryonal carcinomacells, bothmacroH2A1andmacroH2A2
localize to developmental genes (10). A similar genomic distribution
formacroH2A1was confirmed in humanfibroblasts and breast can-
cer cells (19). MacroH2A occupancy generally correlates with gene
repression and low transcriptional activity (10, 19). Accordingly in-
hibiting macroH2A increased the transcription levels, or facilitated
the activation, of target genes (1, 10, 12, 23). The view of macroH2A
as a pure repressor was challenged by two groups reporting that the
presenceofmacroH2A1was essential for activating genes in response
to stimuli such as heat shock or serum deprivation (19, 35). The
physiological relevance of macroH2A function is best illustrated in
vivo, where macroH2A was required for proper zebrafish develop-
ment (10). In lung and breast cancer, loss of macroH2A1.1 and
macroH2A2correlatedwithpoorprognosis (40). Inaddition, inmel-
anoma, loss of macroH2A1 andmacroH2A2 promoted progression
to ametastatic state (27). At present, it is not understood which bio-
logical functions ofmacroH2Adependon its repressive function and
which on its activating capacity.
Here, we provide insight for the role of macroH2A in embry-
onic and adult stem cells. We found that in ES cells macroH2A1
regulates the crucial balance between self-renewal and differenti-
ation commitment, acting on the side of differentiation. We fur-
ther demonstrate that it is the newly recognized function of
macroH2A in transcriptional activation bywhichmacroH2Apro-
motes differentiation. This new role for macroH2A seems not to
be limited to ES cells, as we also have observed similar effects in the
pluripotent cell compartment of primary human keratinocytes.
MATERIALS AND METHODS
Antibodies and plasmids. We used the antibodies against tubulin and
the anti-Flag M2 from Sigma-Aldrich, H3 C-terminal, H3K27me3,
H3K4me2, andH3K4me3 fromUpstate, EZH2 (36), Ki67 from BD Phar-
mingen, Oct3/4 from BD Pharmingen, involucrin from AbCam, S100,
GFAP, and the cytokeratin clones AE1/AE3 from DakoCytomation,
macroH2A1.1 (40), and macroH2A1 and macroH2A2 (10). Expression
plasmids and pLKO-1 constructs were generated with standard PCR and
cloning techniques. pRetroSUPER constructs were described previously
(10).
Cell culture and gene transfer. The mouse ES cell line E14 (25) was
maintained in minimal essential medium (MEM) (Sigma) supplemented
with 20% fetal bovine serum (FBS) (HyClone), 1% penicillin-streptomycin,
1% GlutaMAX, 1% nonessential amino acids, 1% sodium pyruvate, and
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0.2%-mercaptoethanol, in the presence of leukemia inhibitory factor (LIF)
corresponding to 1,000 U/ml. The cells were propagated every 2 days by
trypsinizing and plating onto 0.1% gelatin-coated plates, with a split ratio of
1:8. Primary humankeratinocytes (PHKs), isolated fromadult foreskin,were
grown on mitomycin C-treated J2-3T3 feeder cells in FAD medium (1 part
Ham’s F-12medium, 3 parts DulbeccoMEM [DMEM], 1.8 104 M ade-
nine) supplementedwith 10% fetal bovine serum, 0.5g/ml hydrocortisone,
5 g/ml insulin, 1010 M cholera toxin, and 10 ng/ml epidermal growth
factor (EGF). J2-3T3 cells were previously expanded in DMEM containing
10%donor bovine serumand treatedwith 4g/mlmitomycinC (Sigma) for
2 h. For the colony formation assay, 103 PHKs were seeded per well in a
six-well plate on top of a layer of J2-3T3 cells. At the end of the experiment,
cells were stained with crystal violet. HEK293T andGP2 cells were cultivated
in DMEM supplemented with 10% FCS. Retroviral and lentiviral infections
were performed essentially as described previously (2, 8). For suppression of
macroH2A1, cellswere infectedwithvectors expressingeither specificor con-
trol small hairpin RNAs and selected with 2g/ml puromycin.
Stem cell differentiation and teratoma formation. For neuronal dif-
ferentiation, 1Mretinoic acidwas added directly to the plates in LIF-free
medium. Replating assays were performed in analogy to experiments de-
scribed elsewhere (17). For embryoid body (EB) formation, 103 cells were
seeded in 20-l hanging drops on petri dish lids and grown in the absence
of LIF. After 48 h, EBs were collected and grown in suspension in non-
coated petri dishes. The medium was changed every 2 days until harvest.
For teratoma formation, we injected 200 l phosphate-buffered saline
(PBS)–25% Matrigel containing 1  106 mES cells subcutaneously in
both laterals of Swiss nudemice. All of the teratomas analyzed were local-
ized at the site of injection, and none of them showed any signs of invasion
or metastasis at the time of being sacrificed. They did not appear to affect
the health of the host mice.
Protein analysis. Lysis and Western blot analyses were performed as
previously described (9, 42). Immunohistochemistry and immunofluo-
rescence on paraffin-embedded sections were performed as described
previously (5, 24). For the separation of nucleosolic and chromatin frac-
tions, we have used a modified version of the Dignam protocol. In brief,
isolated nuclei were resuspended in low-salt buffer (20 mM HEPES, pH
7.9, 1.5 mM MgCl2, 0.2 mM EDTA, 20 mM KCl, 25% [wt/vol] glycerol,
0.5 mM dithiothreitol [DTT]). The soluble nucleosolic fraction was ex-
tracted during 30 min of constant moderate agitation after addition of 1
volume of high-salt buffer (20 mM HEPES, pH 7.9, 1.5 mM MgCl2, 0.2
mM EDTA, 800 mM KCl, 25% [wt/vol] glycerol, 1% NP-40, 0.5 mM
DTT). Chromatin was pelleted by ultracentrifugation for 1.5 h at
200,000 g.
Analysis of gene expression and enriched chromatin fractions. Fol-
lowing the supplier’s instructions, RNA was purified from 2  106 cells
using the Qiagen RNeasy minikit, with a DNase 1 digestion step to avoid
any potential DNA contamination. Total RNA (1 g) was reverse tran-
scribed using a cDNA synthesis kit (Roche) and oligo(dT) primers. Rela-
tive cDNA levels were quantified by quantitative PCR (qPCR). Values
were normalized to the expression of two housekeeping genes (Rpo and
Gapdh for mES cells andHPRT andGAPDH for keratinocytes). Chroma-
tin immunoprecipitation (ChIP) experiments were performed and ana-
lyzed essentially as previously described (18). The sequences of all oligo-
nucleotides used here are provided as additional material at http://tinyurl
.com/buschbeck-lab. Results cited as data not shown are also available on
the group’s homepage. Unless indicated otherwise, ChIP results are given
as the percentage ofChIP relative to the inputmaterial. ForChIP sequenc-
ing (ChIP-seq), 10 ng of DNA was enriched by ChIP and quantified with
the PicoGreen fluorescence method. Library generation and direct mas-
sive parallel sequencing on an Illumina genome analyzer were performed
according to the suppliers’ instructions.
Data analysis and statistics. Reads of 36 bp were mapped onto the
mouse genome (Mus musculus reference strain NCBIM37/mm9;
UCSC) using the Bowtie short read aligner (version 0.11.3) (28); a
maximum of 2 mismatches and a 28-bp seed size were allowed. Only
reads mapping to a single position in the genome were used. The
MACS software (v 1.3.6.1) (44) was used for peak calling for the H3K4
and H3K27 reads, and the CCAT software (v 2.0) (43) for the
macroH2A reads, with a sliding window size of 1,000 bp using the IgG
signal as background. The R/BioConductor (20) ChIPPeakAnno, and
biomaRt packages were used to annotate (15, 45). Genes were consid-
ered to be targets if their peak overlapped with the gene body or with
the 10-kb upstream promoter region. The DAVID functional cluster
analysis was used to annotate functionally related groups of genes (26).
For the correlation of ChIP data with gene expression, transcripts were
grouped in categories 0 (no signal) and 1 (very low) to 5 (high) accord-
ing to the spot intensity of corresponding probes on Agilent human
expression arrays generated by Morey and colleagues (31).
Unless indicated otherwise, error bars represent the standard devia-
tions and asterisks represent P 0.05, as calculated with two-tailed t tests.
For nonparametric distributions, P values were determined by theMann-
Whitney test.
Microarray data accession number.Data from the ChIP-seq analysis
have been deposited in the Gene Expression Omnibus under accession
number GSE35087.
RESULTS
MacroH2A1.2 occupies differentiation genes in mouse ES cells.
We set out to assess the relative expression levels of all macroH2A
forms in self-renewing mouse E14 ES cells. On the protein level,
macroH2A1 is expressed to a greater level than macroH2A2 (Fig.
1A). Quantifying the relative abundance of mRNA, we found that
mES cells contained 7 timesmoremessenger formacroH2A1 than
macroH2A2 (Fig. 1B). Moreover, all of the macroH2A1 mRNA
encoded the splice variant macroH2A1.2 (Fig. 1B). This could be
further confirmed by taking advantage of a unique restriction site
in one of the two mutually exclusive exons of the macroH2A1
splice variants (Fig. 1C). Since these data suggested that the
macroH2A1.2 form constitutes more than 80% of all cellular
macroH2A, we decided to focus on this isoform by using an anti-
body that was generated against its macro domain (10). We en-
richedmacroH2A1-bound chromatin frommES cells by chroma-
tin immunoprecipitation and analyzed the coprecipitated DNA
by direct massive parallel sequencing. Nonspecific IgG was in-
cluded as a negative control.
We were able to unequivocally map around 15 and 12 million
sequences for macroH2A1 and IgG, respectively, to the mouse
reference genome. Using a sliding window of 1,000 bp and IgG as
a background control, we identified a total of 2,560 macroH2A1-
enriched regions (for more detail, see File S1 in the supplemental
material). Since the ChIP-seq analysis was not saturated, these
2,560 have to be considered a sample of macroH2A-enriched
chromatin rather than a comprehensive description. Around 25%
of all these peaks overlapped with annotated 494 genes or with
their 10-kb promoter regions (Fig. 1D). Zooming in on the tran-
scriptional start sites (TSS) of these target genes, we found a min-
imum of macroH2A occupancy at the immediate TSS (Fig. 1E).
Genes with increasing expression levels were progressively under-
represented among macroH2A1 target genes (Fig. 1F). Next, we
usedDAVID functional cluster analysis (26) to annotate function-
ally related groups of genes that are enriched for macroH2A1 in
mES cells. Several of the top-scoring clusters were directly related
to the regulation of developmental processes (Fig. 1G; see also File
S1). These clusters contain many genes that are relevant for cell
differentiation, including those that encode secreted ligands (such
as Wnt8a), cell surface receptors (such as FGFR1), and transcrip-
tion factors (such as Pax3).
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MacroH2A1 is required for a full response to neuronal dif-
ferentiation. Since neuronal differentiation was among the top
functional clusters that were annotated for macroH2A1 target
genes (Fig. 1G), we decided to initially focus our attention on this
process. Neuronal differentiation of mouse ES cells can be in-
duced by the addition of retinoic acid (RA) (21). In accordance
with the previous observation that macroH2A1 is upregulated
upon differentiation of stem cells (14, 38), we found that the ad-
dition of RA resulted in an increase of macroH2A1.2 on the pro-
tein and RNA levels (Fig. 2A and B). The macroH2A1.2 level di-
rectly dictates the loading of macroH2A1.2 onto chromatin, as no
macroH2A1 could be detected in the nucleosol (data not shown).
MacroH2A1.1 andmacroH2A2 are also increased upon treatment
with RA but remain expressed at much lower levels than
macroH2A1.2 (Fig. 2B). We next analyzed the occupancy of
macroH2A in self-renewing and differentiating cells on a panel of
target genes by chromatin immunoprecipitation (ChIP). We fo-
cused our attention on genes known to be involved in differenti-
ation, including Pax3, Msx1, and Hand1. We could confirm the
enrichment of macroH2A1 on these genes in respect to house-
keeping genes and genes that encode the core pluripotency-main-
taining transcription factors Oct4, Nanog, and Sox2 (Fig. 2C).
Concomitant with the RA-induced increase in macroH2A1 ex-
pression, macroH2A1 occupancy was augmented during neuro-
nal differentiation on almost all target genes (Fig. 2C). The same
held true for the less highly expressed macroH2A2 (data not
shown). Next, we had a closer look at Pax3 as one of the
macroH2A1 target genes. RA-induced Pax3 transcription cooc-
curred with increased loading of macroH2A1 that was most pro-
nounced at TSS distal regions of the upstream promoter and the
transcribed region (Fig. 2D).
To test whether macroH2A is required for the proper response
of differentiation genes, we used two different short hairpin RNAs
(shRNAs) directed against the shared part of macroH2A1 splice
FIG 1 MacroH2A1.2 is enriched on genes that regulate differentiation in ES cells. (A) Lysates from E14 mouse embryonic stem (mES) cells were analyzed by
Western blotting together with extracts containing similar amounts of Flag (F)-epitope-tagged macroH2A1.2 and macroH2A2 (marked with arrowheads). (B)
The relative mRNA levels of macroH2A forms were analyzed by quantitative RT-PCR and normalized to two housekeeping genes and equimolar reference
samples. (C) MspI restriction fragment length polymorphism analysis of an RT-PCR product spanning the variant exon allows the macroH2A1 splice forms to
be distinguished. Murine cells expressing exclusively macroH2A1.1 were included as control. (D) Enriched regions (peaks) of macroH2A1 identified bymassive
parallel sequencing of DNA immunoprecipitated by anti-macroH2A1 from chromatin are shown in respect to annotated genes. (E) The positions of the peaks
shown in panel D were plotted against annotated transcription start sites (TSS). (F) Correlation of mH2A1 occupancy with the transcriptional level. Genes were
grouped into five expression categories according to probe intensities on Agilent Expression arrays (0, no signal/expression; 1 to 4, very low to high expression).
(G)DAVID functional annotation cluster analysis ofmacroH2A1 target genes. All clusters with an enrichment score of2 are represented. Asterisks indicate the
P value of the top-ranked component of each cluster: *,P 104; **,P 105; and ***,P 106. Gene examples are given at the right. Formore details on panels
D to G, see File S1 in the supplemental material.
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variants. Both shRNAs efficiently repressed macroH2A1 expres-
sion even after 3 days of RA treatment (Fig. 3B), and no compen-
sation by macroH2A2 occurred (data not shown). Importantly,
this strong reduction of macroH2A levels did not affect prolifera-
tion or survival of mES cells (data not shown). As shown in Fig.
3A, loss of macroH2A1 significantly reduced the RA-induced ac-
tivation of its target genes involved in differentiation, including
Pax3,Msx1, andHand1, although it did not affect basal transcrip-
tion levels in self-renewing stem cells. The RA nonresponsive
genes Upp1, Srcap, and Hmg20A were not affected by the knock-
downofmacroH2A1. Activation of differentiation genes is known
to trigger several negative feedbackmechanisms that contribute to
the inactivation of core pluripotency factors; this inactivation is
required for the proper execution of the differentiation program
(reviewed in reference 33). As expected, addition of RA reduced the
mRNA levels of the threemainpluripotency regulators,Nanog,Oct4,
and Sox2 (Fig. 3A). However, the repression of those factors is less
efficient inmH2A1-deficientmES cells, resulting in abnormally high
expression of pluripotency transcription factors in those cells com-
pared to that in control cells after RA-induced differentiation
(Fig. 3A). In line with this, Oct4 protein could be detected in sh-
macroH2A1 cells but not control cells when treated with RA (Fig.
3B).Next, we tested the pluripotency retained by the cells after 6 days
of differentiation. In control cells and cells defective for macroH2A,
Oct4RNA levels are very low after 6 days of RA treatment.When RA
medium is replaced by ES cell maintenance medium, control cells
maintain very low levels of Oct4 expression while macroH2A-defi-
cient mES cells show a significant increase ofOct4mRNA.
FIG 2 MacroH2A is retained on its target genes upon induction of neuronal differentiation. Cells were treated with 1 M retinoic acid (RA) for 3 days. (A)
Western blot analysis ofmacroH2A1 andmacroH2A2 in total nuclei. Oct4was included as a differentiation control, and histoneH3was used as a loading control.
(B) The relative mRNA levels of total macroH2A1, macroH2A2, and the splice variants macroH2A1.1 andmacroH2A1.2 were analyzed by quantitative RT-PCR
and normalized to two housekeeping genes and equimolar reference sampled. (C) The occupancy of macroH2A1 on genes was analyzed by chromatin
immunoprecipitation (ChIP) in self-renewing cells and differentiating cells treated with 1 M RA for 3 days. Error bars denote standard deviation, and n 3.
(D) The mRNA level of Pax3 and the occupancy by macroH2A1 around the transcription start site of Pax3 were analyzed by quantitative RT-PCR and ChIP,
respectively. Error bars denote standard deviation, and n 3.
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MacroH2A1 is critical for proper embryoid body formation.
We next asked whether macroH2A influences only neuronal differ-
entiation or if macroH2A can also affect other lineages. To address
this, we decided to study the function of macroH2A1 during em-
bryoid body formation. Embryoid bodies (EBs) provide an in vitro
model that recapitulates the early differentiation steps of embryonic
development (16). During EB formation, ES cells diverge and enter
into differentiation programs of all three lineages: ectoderm, endo-
derm, and mesoderm. Similarly to what was observed during RA-
induced differentiation, the levels of macroH2A1.2 increased during
EB formation, andmacroH2A1.2 accounted for the bulk amount of
cellular macroH2A at all time points (data not shown). To study the
role of macroH2A1 during the differentiation of mES cells into EBs,
we initially used the ES cells that stably expressed shRNAmH2A1#1,
which resulted in stable reduction of macroH2A1 throughout the
process of EB formation (Fig. 4A and B). In analogy to our previ-
ous results with RA treatment, no compensatory upregulation of
macroH2A2 was observed (Fig. 4B). As shown in Fig. 4C, EBs
generated from sh-macroH2A1 cells and control cells showed
phenotypical differences that weremost pronounced at late stages
of EB formation, as shown for day 8. MacroH2A1-deficient EBs
were smaller and showed less of the typical cavitation of late-stage
EBs than control EBs. Semiquantitative analysis of mRNA levels
demonstrated that EBs derived from sh-macroH2A1 cells retained
abnormally high levels ofNanog,Oct4, and Sox2 expression at late
stages (Fig. 4D). Aberrantly high levels of Oct4 in EBs at day 9
could also be observed on the protein level (Fig. 4A). The activa-
tion of differentiation genes of all embryonic lineages was partially
impaired in the absence of macroH2A1 (Fig. 4D), with the activa-
tion not being fully achieved (forT/Brachyury,Cdx2, andHand1),
delayed (for GATA4 and nestin), or both (for Pax3). Finally we
tested additional shRNAs for macroH2A1 and macroH2A2 on a
representative differentiation and pluripotency gene in late-stage
EBs. All four macroH2A-specific shRNAs tested significantly in-
creased the levels of Nanog (Fig. 4E). Both macroH2A1-specific
shRNAs further reduced the levels of Gata4 at day 6 of the EB
formation process, while shRNAs directed against macroH2A2
did not. It is interesting to note that some of the shRNAs for
macroH2A1 or macroH2A2 also reduced the respective other
mRNA.
The presence of macroH2A1 on the promoters of differentia-
tion genes whose activation is partially impaired by the suppres-
sion of macroH2A1 expression suggested a direct mechanism.
MacroH2A1 target genes partially but significantly overlapped
with genes marked by trimethylation of lysine 27 alone or in com-
bination with active lysine 4 methylation (data not shown). Since
depletion of macroH2A1 did not affect significantly the level of
either histonemethylation on its target genes (data not shown), at
the present we can exclude a defect in the maintenance of these
so-called bivalent domains as a possible mechanism.
MacroH2A-deficient teratomas showamassive expansion of
immature carcinoma tissue. We next analyzed the impact of
macroH2A on the differentiation of mES cells in xenografts. When
injected into immunosuppressed mice, mES cells form teratomas,
FIG 3 Depletion of macroH2A1 interferes with the neuronal differentiation of mES cells. (A) Expression levels of differentiation and pluripotency genes were
analyzed byRT-qPCR inmES cells that were untreated or treatedwith 1MRA for 3 days.Upp1, Srcap, andHmg20awere included as controls. Error bars denote
standard deviation;n 3; *,P 0.05. (B)Crude cell lysateswere analyzed byWestern blotting using anti-Oct4,macroH2A1, and histoneH3 antibodies. (C)mES
cells were treated with 1 MRA for 6 days, after which RA medium was removed and replaced by LIF maintenance mES cell medium. Cells were collected and
subjected to RNA extraction and quantitative RT-PCR (17). Error bars denote the variances of results from two independent experiments.
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which are tumors composed mainly of differentiated cells derived
fromall three germ layers. By injecting either sh-macroH2A1or con-
trol mES cells, we observed that a loss of macroH2A1 provoked an
obvious increase in teratoma growth (Fig. 5A). In addition to differ-
entiatedcells, teratomasgenerated frommurineEScells areknownto
contain a small proportionofmalignant, undifferentiated carcinoma
tissue (4). This primitive tissue wasmassively expanded in teratomas
formed by macroH2A1-deficient mES cells (Fig. 5B). Importantly,
the knockdown of macroH2A1 was sustained in these teratomas, al-
beit to a lesser extent than in the initial mES cell culture (Fig.
5C). Mesodermic cartilage, endodermic pulmonary epithe-
lium, and neuronal tissues (including neuroglia) were the ma-
jor differentiated representatives of the three germ layers in all
teratomas, but their proportion was tendentially reduced in
sh-macroH2A1 cell-derived teratomas (Fig. 5B). In line with
these results, we found significantly increased mRNA levels of
the pluripotency genes Oct4 and Sox2 in the bulk teratoma
tissues derived from sh-macroH2A1 mES cells (Fig. 5C).
MacroH2A1 levels determine the differentiation propensity
of PHKs.Having established a function for macroH2A in embry-
onic stem cells, we wished to address whether macroH2A has a
similar regulatory function in adult stem cells. Staining of human
scalp skin sections demonstrated that macroH2A1 is more highly
expressed in the upper differentiated layers than in the basal cell
layers that contain the stem cells and their activated progeny of
transit-amplifying cells (Fig. 6A). Indeed, higher macroH2A1 lev-
FIG 4 Depletion ofmacroH2A1 interferes with proper embryoid body formation. (A)Western blot analysis of macroH2A1 andOct4 in self-renewingmES cells
and in embryoid bodies (EBs) at day 9. Histone H3 was used as loading control. (B) The mRNA levels of macroH2A1 and macroH2A2 in control cells and after
shRNA-mediated knockdown ofmacroH2A1 were analyzed at different time points of EB formation and normalized to equimolar reference samples. Error bars
denote standard deviation; n  3; *, P  0.05. (C) Light microscopic analysis of EBs revealed that the normal shapes and sizes are perturbed in macroH2A1-
deficient cells. Scale bar, 500 m. Arrowheads indicate normal stage-specific cavitation. (D) Transcript expression levels of genes that regulate pluripotency
(Nanog,Oct4, and Sox2) and differentiation (T/Brachyury, mesoderm; Gata4, endoderm;Hand1, Pax3, and nestin, ectoderm; and Cdx2, trophoectoderm) were
analyzed by quantitative RT-PCR. Error bars denote standard deviation; n 3; *, P 0.05. (E) ThemRNA levels ofNanog,Gata4,macroH2A1, andmacroH2A2
were analyzed in ES cells expressing different hairpins directed againstmacroH2A1 andmacroH2A2 at day 6 of EB formation (day 9 forNanog). Error bars denote
standard deviation; n 3; *, P 0.05.
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els correlate with the presence of the differentiation marker invo-
lucrin (Fig. 6B). Therefore, we turned to primary cultures of hu-
man keratinocytes (PHKs) derived from adult foreskin that
expressmoremacroH2A1 thanmacroH2A2 (Fig. 6C). Semiquan-
titative analysis of the relative RNA levels of all macroH2A forms
suggests thatmacroH2A1.2 andmacroH2A2 in an estimated ratio
of 2:1 constitute the bulk amount of cellular macroH2A (Fig. 6D).
The heterogeneous cultures of PHKs contain the stem cells of the
interfollicular epidermis, as demonstrated by transplantation ex-
periments that show that these specialized adult stem cells can give
rise to all cell types of the skin (29). In culture, PHK cells grow into
three-dimensional clones that differentiate from bottom to top.
This differentiation process can be visualized by staining for invo-
lucrin, which is expressed in the upper layers formed by differen-
tiated cells (Fig. 6E). Similar to the skin sections, macroH2A1
expression positively correlated with the differentiation of PHKs
grown as colonies (Fig. 6E).
To study how themacroH2A1 level influences the differentiation
process, we next generated PHKs that overexpressed the epitope-
taggedmacroH2A1.2 (Fig. 7A).Whenseededat lowcellnumbers, the
bulk of PHKs stop proliferating and differentiate, while only stem
cells and late-derived, transit-amplifying cells are able to sufficiently
self-renew to expand into holoclones (3). As shown in Fig. 7B, over-
expression of macroH2A1.2 strongly reduced the number of holo-
clones. The overexpression of macroH2A1.1 and macroH2A2 had
the same effect (data not shown). Importantly, overexpression of
macroH2A did not affect the proliferation or survival of PHKs (data
not shown). The observation that the level of the differentiation
marker involucrin was increased in macroH2A1.2-overexpressing
PHKs (Fig. 7C) further substantiated increased differentiation as the
most likely mechanism for the observed reduction in colony forma-
tion (Fig. 7B). In the converse experiment, repressionofmacroH2A1
or macroH2A2 by stable shRNA interference increased the number
of holoclones (Fig. 7D and E). Accordingly, cells with reduced
macroH2A levels further displayed a reduction in involucrinmRNA
levels (Fig. 7F). Together, these results suggest thatmacroH2Aaffects
the balance of self-renewal anddifferentiationnot only inES cells but
also in the adult stem cells of the interfollicular epidermis.
DISCUSSION
Here, we show that macroH2A plays a critical role in the differen-
tiation of ES cells. Using shRNA-mediated knockdown, we stud-
ied the role that macroH2A plays in differentiation by three
different approaches: RA-induced neuronal differentiation, EB
formation, and in vivo differentiation in teratoma xenografts. We
found that during neuronal differentiation and EB formation,
macroH2A1 deficiency resulted in reduced or delayed activation
of differentiation genes, many of which were shown to be direct
FIG 5 In vivo loss of macroH2A1 results in an expansion ofmalignant, undifferentiated carcinoma tissue. (A)Weight of teratomas generated by sh-macroH2A1
and control mES cells 3 weeks after injection.*, P 0.019, as determined by nonparametricMann-Whitney testing. (B) Hematoxylin-eosin (H&E) stainings and
immunohistochemical analyses of teratoma sections. Malignant undifferentiated carcinoma tissues were identified by two independent pathologists and
indicated by dotted lines. Different markers were used to stain tissues originating from all three lineages: S100 for cartilage (mesoderm), glial fibrilary acidic
protein for neuroglia (ectoderm), and cytokeratins for epithelial cells (endoderm). Quantifications on the right were done on complete cross-sections of three
samples. Error bars denote standard deviation; *, P 0.05. (C) Quantitative RT-PCR analysis of RNA isolated from bulk teratoma tissue. Values are shown with
respect to the mRNA levels in self-renewing stem cells, which were set to 1. Error bars denote standard deviation; n 3; *, P 0.05.
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target genes of macroH2A1. Loss of macroH2A1 further resulted
in the incomplete inactivation of the pluripotency genes that en-
code the key regulatory transcription factors Sox2, Nanog, and
Oct4. In self-renewing stem cells, neither differentiation genes nor
pluripotency genes were affected by the loss of macroH2A. Al-
though macroH2A, and in particular macroH2A1.1, is known to
inhibit proliferation in cancer cell lines (34), in mES cells
macroH2A did not affect cell proliferation or viability. We con-
clude that macroH2A affects the differentiation but not the
self-renewal of mES cells. Our data suggest that in ES cells
macroH2A exerts its effect at least in part through a proacti-
vating function on target genes, which include important reg-
ulators of differentiation (Fig. 7G). In teratoma xenografts, the
reduction of macroH2A provoked a massive expansion of ma-
lignant, undifferentiated carcinoma tissue. This tissue is a mi-
nor but intrinsic component of mES cell-derived teratomas
that consists of cells failing to enter differentiation (4). Taken
together, our data suggest that macroH2A modulates the intri-
cate balance between self-renewal and commitment to differ-
entiation by contributing to the proper execution of differen-
tiation programs.
Our data stand in direct contrast with a recent publication
from Tanasijevic and Rasmussen, which reported that macroH2A
had no influence onX chromosome inactivation ormurine ES cell
differentiation (41). This apparent discrepancy could be explained
in several ways. First, the different genetic backgrounds of the ES
cells used in the two studies might have influenced the penetrance
and severity of the loss-of-function phenotype. It has long been
known that different genetic backgrounds can impact the pheno-
type, and this is well documented for a large number of genes (32).
Second, by relying on largely qualitative readouts and measure-
ments at single time points during differentiation, the study by
FIG 6 MacroH2A1 expression correlates with the differentiation of human keratinocytes. (A and B) Gradual upregulation of macroH2A1 from the basal to the
more differentiated cell layers in a human scalp skin section, as shown by immunofluorescence. Cells were counterstained for the proliferation marker Ki67 (A)
or the differentiation marker involucrin (B) and DAPI. Scale bars, 50 m. (C) Lysates from primary human keratinocytes (PHKs) were analyzed by Western
blotting together with extracts containing equivalent amounts of Flag (F)-tagged macroH2A1.2 and macroH2A2. (D) The relative mRNA levels of macroH2A
forms were analyzed by quantitative RT-PCR and normalized to equimolar reference samples. (E) Confocal microscopy sections of a three-dimensional PHK
colony. Involucrin was used to mark the differentiated cells present in the upper layer. DNA was counterstained with DAPI. Scale bars, 100 m.
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Tanasijevic and Rasmussen might have missed the influence of
macroH2A on the expression levels of differentiation genes that
we observed by quantitative reverse transcriptase PCR (RT-PCR)
at several, but not all, time points during differentiation. Further-
more, in xenografts, they showed that ES cells with strongly re-
duced macroH2A levels are able to form teratomas containing
components of all three lineages (41). We corroborated this find-
ing but also observed that primitive and poorly differentiated car-
cinoma tissue was strongly expanded in macroH2A1-deficient
samples. Finally, we cannot exclude the possibility that the inter-
fered ES cells used in the two studies might have differed in their
residual macroH2A level to a point that could also explain the
apparent discrepancies of the results.
Contradictory observations in macroH2A-deficient animals
further fuel this controversy. In zebrafish, macroH2A2 knock-
down provoked several developmental defects (10), while inacti-
vation of the macroH2A1 gene in mice resulted in only mild phe-
notypes, including defects in lipid metabolism (6, 12). The
knockoutmice generated in different genetic backgrounds further
differed in the severity of this metabolic defect. Boulard and col-
leagues observed a massive accumulation of fat (steatosis) in the
livers of female animals, which was not reported by Changolkar
and coworkers. Interestingly, this steatosis phenotype had a par-
tial but stable penetrance of close to 50% in a mixed genetic back-
ground that was composed equally of two different mice strains
(6). This suggests that the genetic background indeed strongly
affects the impact of macroH2A1 deficiency.
Although macroH2A has long been considered to be a merely
repressive chromatin mark, two publications have pointed out
that, although macroH2A preferentially occupies repressed genes
or genes with low transcriptional activity, it might actually be re-
quired to make these genes sensitive to activating cues. Thus, in
HeLa cells, macroH2A1.1 was found to occupy the promoter of
theHSP70.1 gene and to be essential for its transcriptional activa-
tion in response to heat shock (35). Furthermore, macroH2A1
was shown to be required for the activation of a panel of direct
target genes upon serum deprivation of MCF7 breast cancer cells
(19). Our data now provide evidence for the physiological rele-
vance of the still poorly recognized proactivating function of
macroH2A in ES cell differentiation. In particular, we show that
the presence of macroH2A1 on differentiation genes was required
for their adequate induction while having no effect on basal activ-
FIG 7 MacroH2A1 limits the self-renewal capacity, and favors the differentiation, of primary human keratinocytes. (A) Western blot analysis of lysates from
PHKs overexpressing Flag (F)-tagged macroH2A1.2 using anti-FLAG, macroH2A1, and tubulin antibodies. (B) Colony formation analysis of the same PHKs
grown on feeder cells. Error bars denote standard deviation; n 3; *, P 0.05. (C) The mRNA level of involucrin was analyzed by quantitative RT-PCR. Error
bars denote standard deviation; n 3; *, P 0.05. (D) Efficient knockdown ofmacroH2A1 andmacroH2A2was assessed byWestern blot. (E) Colony formation
analysis of the same cells. Error bars denote standard deviation; n  3; *, P  0.05. (F) Expression analysis of involucrin by quantitative RT-PCR. Error bars
denote standard deviation; n 3; *, P 0.05. (G) Cartoon illustrating how macroH2A affects the balance of self-renewal and differentiation. The presence of
macroH2A on regulatory differentiation facilitates their activation and thereby the commitment of stem cells to differentiation.
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ity. Our results thus extend the previous findings and further sup-
port the role of macroH2A in gene activation, which we suggest is
at least partially responsible for its regulatory function during dif-
ferentiation and developmental processes. The recent observation
thatmacroH2A inhibited reprogramming by nuclear transfer (37)
further suggests that macroH2A also contributes to the mainte-
nance and stability of the differentiated epigenome.
The macroH2A1 ChIP-seq experiment reported here demon-
strates that macroH2A1marks genes encoding developmental regu-
lators in mES cells and thus confirms previous results in human
NT2/D1 cells (10). Taking into account thatmostmacroH2A1peaks
were outside genes and that macroH2A-enriched regions were sug-
gested to be large (13, 19, 30), it is perhapsmore correct to state it the
other way around: developmental genes tend to be embedded in
macroH2A1-positive chromatin domains. The ChIP-seq analysis
of macroH2A1 reported here, with its 15 million reads, was far
from reaching saturation. Based on the particular distribution of
macroH2A in large domains, we can extrapolate that two things
would be needed to obtain saturation and thus full resolution and
a comprehensive picture of genomic macroH2A1: first, a much
larger number of reads, and second, improved antibodies that can
generate ChIP data with better signal-to-noise ratios.
In order to fully understand themolecular aspects of macroH2A,
we need to first understand how macroH2A-containing chromatin
domains are established and how the presence of macroH2A and
most likely its binding partners (of which only few have been deter-
mined so far) dictate the behavior of embedded genes. Furthermore,
we will have to address the question of whether the correlation of
macroH2Awith differentiation is universal or, if instead,macroH2A
regulates a limited number of specific lineage-choice decisions in
early development and during adult tissue homeostasis.
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